News

CLEAR Partners with CMS to Enhance Medicare Digital Identity

CLEAR Partners with CMS to Enhance Medicare Digital Identity

CLEAR Partners with CMS to Enhance Medicare Digital Identity

NEW YORK — CLEAR (NYSE: YOU), known for its cutting-edge secure identity solutions, has announced a significant contract with the Centers for Medicare & Medicaid Services for advancing digital identity verification for Medicare beneficiary and provider accounts on Medicare.gov. This initiative is part of a broader effort to enhance security and improve user experience in healthcare.

Integration of CLEAR1 at Medicare.gov

Expected to launch in early 2026, CLEAR1, the company's state-of-the-art identity platform, will be integrated into Medicare.gov. This platform will streamline account creation, facilitate account recovery, and enable easier access to private health information.

Addressing Identity Risks in Healthcare

The healthcare sector faces increasing identity risks, with attackers leveraging publicly available data, AI-generated identities, and deepfake technology to commit fraud. CLEAR1 aims to tackle these challenges by implementing multi-layered verification processes that significantly reduce identity theft and fraud. This approach not only protects sensitive information but also fosters greater trust in accessing healthcare services smoothly and securely.

Supporting CMS’s Health Tech Ecosystem

This collaboration aligns with CMS’s initiative aimed at creating a more integrated and patient-centered healthcare system. By implementing a secure and reusable digital identity, CLEAR1 will help achieve the goal of minimizing paperwork for millions, enhancing patients' access to their healthcare services seamlessly.

Statements from Leadership

“At CLEAR, our mission is to connect individuals to their true identities securely and efficiently,” expressed Caryn Seidman Becker, CEO of CLEAR. “This partnership with CMS reflects our commitment to enhancing access to healthcare and protecting beneficiaries against identity fraud.” David Bardan, General Manager and Head of Healthcare at CLEAR, added that the outdated processes currently in place create barriers to care and that CLEAR1's high-assurance identity solution will help in overcoming these challenges for millions of Americans.

Benefits of CLEAR1

CLEAR1 is designed to comply with HIPAA regulations and has received certification from the Kantara Initiative for its robust identity assurance levels. These attributes confirm its capacity to serve as a trusted identity framework within the complex healthcare landscape. With capabilities to enhance operational efficiency, CLEAR1 can lessen the volume of identity-related support requests while simultaneously combating fraud.

Partnerships with Major Healthcare Organizations

Pending implementation, beneficiaries may soon be able to confirm their identities with a simple selfie, a method already in use by partners like Epic, Sharecare, and Welldoc. Other healthcare institutions such as Wellstar Health, University of Miami Health, Hackensack Meridian Health, Community Health Network, and Ochsner Health are also collaborating with CLEAR1 to create a safer and more efficient healthcare environment.

About CLEAR

CLEAR is dedicated to enhancing security and streamlining experiences. With a thriving membership of over 36 million and a growing network of partners, CLEAR’s identity platform is set to redefine how individuals interact with healthcare and other systems globally. The goal is to maintain privacy while empowering users, ensuring they control their own information without compromising sensitive personal data.

Frequently Asked Questions

What is the CLEAR1 platform?

CLEAR1 is a secure identity verification platform designed to streamline account management and enhance security for users, particularly within Medicare.gov.

How will CLEAR1 benefit Medicare beneficiaries?

By integrating CLEAR1 into Medicare.gov, beneficiaries will experience seamless account creation and access to healthcare information, reducing identity theft and fraud risks.

What measures does CLEAR take to ensure user privacy?

CLEAR is committed to maintaining user privacy. Members have control over their information, and CLEAR does not sell biometric or sensitive personal data.

How does CLEAR1 combat healthcare identity fraud?

CLEAR1 employs multi-layered verification processes that help protect sensitive data and reduce identity-related fraud in the healthcare sector.

Who are CLEAR’s partners in the healthcare sector?

CLEAR collaborates with numerous healthcare organizations, including Epic, Sharecare, Welldoc, and various health systems, to strengthen its secure identity solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 342

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 115

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 165

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights and Updates on Apax Global Alpha Investments

Updated Category News Views 148

Understanding Apax Global Alpha Limited Apax Global Alpha Limited is a prominent player in the investment sector, recognized for its strategic engagements and robust portfolio. The company, trading under the ticker LSE:INVP, has continuous operations, which not only aim at capital growth but also seek to provide substantial value to stakeholders. Key Information Overview...

Continue Reading
Morgan Stanley's Insights on European Oil and Gas Stock Ratings

Updated Category News Views 187

Morgan Stanley's Updated Ratings on European Oil and Gas Stocks Morgan Stanley has recently updated its ratings on several notable European oil and gas companies, showcasing a mixed but insightful outlook for the sector as we head into 2025. The analysts have raised their overall view of the industry from a cautious stance to 'in-line,' reflecting compelling valuations...

Continue Reading
Defense Metals Corp Secures Funding Through Private Placement

Updated Category News Views 203

Defense Metals Corp Successfully Completes Private Placement Defense Metals Corp. (TSXV: DEFN) is excited to announce the closing of the second and final tranche of its private placement, designed to enhance its financial stability and operational capabilities. This recent tranche has brought in gross proceeds amounting to C$576,000, a notable addition to the ongoing...

Continue Reading
Understanding the Alexandria Real Estate Class Action Lawsuit

Updated Category News Views 193

Overview of the Securities Fraud Class Action The latest class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) has raised significant concerns among investors. Recently announced, this lawsuit claims violations of federal securities laws amidst a notable decline in stock value, spurred by an impairment charge of $323.9 million. Implications of the...

Continue Reading
Czech Central Bank Poised for Potential Interest Rate Cuts

Updated Category News Views 112

Czech Central Bank's Potential for Rate Easing The Czech central bank finds itself at a pivotal moment as it considers resuming its monetary easing strategy, potentially as soon as next month. Board member Jan Prochazka has shed light on these developments, emphasizing that while easing could be on the table, uncertainties loom due to various domestic and external...

Continue Reading